Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

AJOVY™ solution for subcutaneous injection 150mg/ml (1.5ml), syringe 1pc

🔥 5 items sold in last 3 hours
25 people are viewing this product
Brand:

$1,831.5

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

L-THYROXINE BERLIN-CHEMIE™ tablets 100mcg, 50pcs

$11.0
Add to cart

OLEOS SUPERCHISTOTEL™ solution 5ml, 1pc

$15.0
Add to cart

Analogs of AJOVY™

L-THYROXINE BERLIN-CHEMIE™ tablets 125mcg, 100pcs

$16.0
Add to cart

L-THYROXINE BERLIN-CHEMIE™ tablets 150mcg, 100pcs

$17.5
Add to cart

L-THYROXINE BERLIN-CHEMIE™ tablets 50mcg, 50pcs

$9.5
Add to cart

L-THYROXINE BERLIN-CHEMIE™ tablets 75mcg, 100pcs

$13.5
Add to cart

Table of Contents

AJOVY™ 150mg Solution 1.5ml Buy Online

Understanding AJOVY for Migraine Prevention

Millions suffer from migraine headaches, significantly impacting their quality of life. For those experiencing frequent and debilitating migraines, exploring preventative treatments is crucial. AJOVY offers a potential solution for managing this chronic condition.

AJOVY (fremanezumab-vfrm) is a prescription medication specifically designed to prevent migraine headaches in adults. It works by targeting a protein called calcitonin gene-related peptide (CGRP), which plays a role in migraine pain pathways. By blocking CGRP, AJOVY helps reduce the frequency and severity of migraine attacks.

The medication is administered via subcutaneous injection, meaning it’s injected under the skin. This method of administration allows for convenient self-administration after proper training by a healthcare professional. The ease of self-injection empowers patients to manage their condition independently.

Importantly, AJOVY is available in two convenient dosage options: a monthly 225mg injection or a quarterly 675mg regimen (administered as three consecutive 225mg injections). The choice of dosage depends on individual needs and response to treatment, as determined by a healthcare provider.

While generally well-tolerated, AJOVY, like any medication, can have potential side effects. These are typically mild and include reactions at the injection site such as redness, pain, or swelling. More serious allergic reactions are rare but require immediate medical attention.

  • Effective Migraine Prevention: Clinically proven to reduce migraine frequency and severity.
  • Convenient Self-Administration: Easy subcutaneous injection allows for home administration.
  • Long-Acting Formulation: Monthly or quarterly dosing options for simplified treatment regimen.
  • Potential Side Effects: Injection site reactions are possible, although usually mild. Rare but serious allergic reactions can occur.
  • Prescription Required: Requires a prescription from a healthcare professional.
  • Cost: May be expensive depending on insurance coverage.

This information is for educational purposes only and should not be considered medical advice. Always consult your physician before starting any new medication, including AJOVY, to determine if it’s appropriate for your specific health needs and to discuss potential risks and benefits.

What is AJOVY?

AJOVY (fremanezumab-vfrm) is a groundbreaking, prescription medication designed to significantly reduce the burden of migraine headaches for adults. It represents a major advancement in migraine treatment, offering a preventative approach rather than simply addressing acute pain episodes. This innovative therapy targets a specific protein, calcitonin gene-related peptide (CGRP), known to play a significant role in the complex mechanisms that trigger migraine pain.

Unlike many other migraine medications, AJOVY offers a unique mechanism of action. It works by selectively binding to and blocking CGRP, thereby disrupting the cascade of events that lead to migraine attacks. This targeted approach can lead to a substantial reduction in both the frequency and severity of headaches. The result is a potential improvement in the overall quality of life for individuals suffering from chronic or episodic migraines.

The medication is administered via a simple subcutaneous injection, meaning it’s injected under the skin. This method is generally well-tolerated and can often be self-administered once proper training is provided by a healthcare professional. This convenient administration method empowers patients to actively participate in managing their own healthcare. The ease of self-injection contributes to improved adherence to the prescribed treatment regimen.

AJOVY’s effectiveness has been rigorously studied and demonstrated in multiple clinical trials. These studies have shown a statistically significant reduction in migraine days experienced by patients compared to those receiving placebo treatments. This evidence underscores the efficacy of AJOVY in providing meaningful relief for individuals struggling with the debilitating effects of frequent migraine headaches. Importantly, the long-term effects of AJOVY are also being actively researched and monitored.

In summary, AJOVY offers a new paradigm for migraine prevention, providing a targeted, convenient, and effective approach to managing this debilitating condition. Its precise mechanism of action and demonstrable clinical efficacy make it a valuable tool in the ongoing quest to improve the lives of those affected by migraine. However, it’s crucial to remember that individual responses to medication can vary, and consultation with a healthcare professional is essential before beginning any treatment.

Dosage and Administration

AJOVY is administered via subcutaneous injection, meaning the injection is given under the skin. This method of delivery is generally well-tolerated and allows for convenient self-administration after proper training by a healthcare professional. The ease and simplicity of self-injection contribute significantly to patient compliance and overall treatment efficacy.

The recommended dosage of AJOVY is tailored to individual patient needs and response to therapy. There are two primary dosing regimens available: a monthly 225 mg injection or a quarterly 675 mg regimen. The quarterly regimen involves three consecutive 225 mg injections administered over a short period. Your doctor will determine the most appropriate dosage based on your specific medical history and the severity of your migraines.

Precise injection technique is crucial to ensure optimal absorption and minimize the risk of adverse reactions. Healthcare providers will provide comprehensive instructions and demonstrations on the proper administration of AJOVY. These instructions typically cover aspects such as selecting the injection site, preparing the injection, and administering the medication correctly. Adhering to these instructions is essential for both safety and efficacy.

The choice between monthly and quarterly dosing depends on several factors. The monthly regimen offers more frequent medication delivery, potentially providing more consistent protection against migraines. The quarterly regimen, while requiring fewer injections overall, may necessitate more careful planning and adherence to the scheduled administration dates. Both options aim to provide effective migraine prevention, but their suitability can vary from patient to patient.

It’s vital to emphasize the importance of following your physician’s instructions carefully regarding the dosage and administration of AJOVY. Regular communication with your healthcare provider allows for close monitoring of treatment efficacy and any potential side effects. This collaborative approach ensures optimal management of your migraine condition and contributes to the best possible treatment outcome.

How to Administer AJOVY

Administering AJOVY involves a straightforward subcutaneous injection, a procedure best learned under the guidance of a healthcare professional. Before attempting self-injection, thorough training is essential to ensure proper technique and minimize the risk of complications. Your doctor or nurse will provide detailed instructions, including demonstrations, to build your confidence and competence in administering the medication.

The injection site should be chosen carefully to ensure optimal absorption and reduce discomfort. Common injection sites include the abdomen, thigh, or upper arm. It’s crucial to rotate injection sites with each dose to prevent localized irritation or tissue damage. Your healthcare provider will advise you on suitable rotation strategies to maximize comfort and effectiveness.

Before administering the injection, it’s important to inspect the AJOVY pre-filled syringe or autoinjector for any signs of damage or discoloration. If anything appears unusual, do not use the device; contact your healthcare provider immediately. Proper handling and preparation of the injection device are critical to ensure the integrity of the medication and the safety of the administration process.

Once the injection site is selected and cleaned, the injection should be administered according to the instructions provided by your healthcare provider. This typically involves inserting the needle at a slight angle into the subcutaneous tissue and slowly injecting the medication. After the injection, gently press on the injection site for a few seconds to minimize any bleeding or bruising. Detailed instructions on these steps will be provided by your healthcare professional.

Following the injection, it’s important to monitor the injection site for any signs of irritation, such as redness, swelling, or pain. While mild reactions are possible, more severe reactions are rare. However, promptly report any concerning symptoms to your healthcare provider. Regular monitoring and communication with your healthcare team is vital for ensuring the safe and effective use of AJOVY.

Storage and Handling

Proper storage and handling of AJOVY are crucial to maintain its efficacy and safety. Improper storage can compromise the medication’s potency and potentially lead to adverse effects. Always adhere strictly to the storage guidelines provided by your healthcare professional or as indicated on the product packaging. Consistent adherence to these guidelines is essential for optimal therapeutic outcomes.

Before initial use, AJOVY should be stored in the refrigerator at a temperature between 36°F and 46°F (2°C and 8°C). Avoid freezing the medication, as this can damage its structure and reduce its effectiveness. Keep the AJOVY in its original carton to protect it from light. Light exposure can degrade the medication, impacting its potency and potentially reducing its therapeutic value.

If refrigeration is unavailable for a short period, AJOVY can be stored at room temperature (up to 86°F or 30°C) for a maximum of 7 days. However, it’s strongly recommended to keep the medication refrigerated whenever possible to ensure optimal stability. Once removed from the refrigerator, use the medication within 7 days or discard it appropriately.

After administering the injection, dispose of the used syringe or autoinjector appropriately. Follow your local guidelines for medical waste disposal. Never reuse syringes or autoinjectors, as this poses a significant risk of infection and contamination. Always prioritize safe and responsible disposal of medical waste materials.

Keep AJOVY out of reach of children and pets. Accidental ingestion or exposure can have serious consequences. Store the medication in a secure location, preferably away from areas with high humidity or extreme temperature fluctuations. Proper storage and handling contribute significantly to ensuring both the safety and efficacy of AJOVY.

Potential Side Effects

While AJOVY is generally well-tolerated, like any medication, it can cause side effects. It’s crucial to understand these potential side effects to make informed decisions about your treatment. Most reported side effects are mild and transient, resolving without intervention. However, serious reactions, though rare, necessitate immediate medical attention.

The most common side effects associated with AJOVY are localized reactions at the injection site. These typically manifest as mild to moderate pain, redness, swelling, itching, or hardening of the skin around the injection area. These symptoms usually subside within a few days. Rotating injection sites with each dose can help minimize the likelihood and severity of these localized reactions.

Less common, but still important to be aware of, are systemic side effects. These may include fatigue, nausea, constipation, or dizziness. While generally mild, these systemic reactions can affect daily activities and should be reported to your healthcare provider. Open communication with your doctor allows for appropriate monitoring and management of any adverse effects.

Serious allergic reactions to AJOVY are rare but possible. Symptoms of a serious allergic reaction can include difficulty breathing, swelling of the face, lips, tongue, or throat, and hives. If you experience any of these symptoms, seek immediate medical attention. Prompt medical intervention is crucial in managing severe allergic reactions.

It is important to note that this information is not exhaustive, and individual experiences with AJOVY can vary. Always consult the complete prescribing information for a detailed list of potential side effects and contraindications. Regular communication with your healthcare provider allows for personalized monitoring and management of any adverse events experienced during treatment.

Pros of Using AJOVY

AJOVY offers several significant advantages for individuals seeking effective migraine prevention. Its targeted mechanism of action, convenient administration, and demonstrable efficacy make it a compelling option for many patients. The potential for improved quality of life is a substantial benefit for those burdened by frequent and debilitating migraine attacks.

One key advantage is AJOVY’s proven effectiveness in reducing migraine frequency and severity. Clinical trials have demonstrated a statistically significant reduction in migraine days experienced by patients compared to placebo. This translates to fewer headaches, less intense pain, and a reduced need for acute migraine medications. This reduction in headache burden can significantly impact daily life.

The convenient method of administration is another significant benefit. The subcutaneous injection, often self-administered after proper training, eliminates the need for frequent visits to a healthcare provider. This ease of use promotes patient adherence to the prescribed treatment regimen, a crucial factor in achieving long-term migraine control. Empowerment through self-administration contributes to better management of the condition.

AJOVY’s long-acting formulation offers flexibility in dosing. Patients can choose between a monthly or quarterly injection schedule, depending on individual needs and preferences. This flexibility simplifies treatment and minimizes the disruption to daily routines. The longer intervals between injections also enhance patient convenience and comfort.

Finally, the targeted mechanism of action, focusing on CGRP, represents a significant scientific advancement in migraine treatment. By specifically targeting a key protein involved in migraine pathways, AJOVY offers a more precise and potentially more effective approach than some older migraine medications. This precision minimizes the potential for broader systemic effects, enhancing both safety and efficacy.

Important Note: Consult Your Doctor

Cons of Using AJOVY

While AJOVY offers significant benefits for migraine prevention, it’s important to acknowledge potential drawbacks. Understanding these limitations allows for a more informed discussion with your healthcare provider to determine if AJOVY is the right treatment for you. Weighing the potential benefits against the potential downsides is crucial for personalized medical decision-making.

One potential downside is the occurrence of injection site reactions. While usually mild and temporary, these reactions can include pain, redness, swelling, itching, or hardening at the injection site. Rotating injection sites and using appropriate injection techniques can help minimize these reactions, but they remain a possibility. Individual sensitivity to the injection can vary considerably.

Although rare, serious allergic reactions are a potential risk. Symptoms can range from mild hives to severe difficulty breathing or swelling of the face, lips, tongue, or throat. Prompt medical attention is crucial if such reactions occur. The rarity of these severe reactions should be balanced against their potential severity.

Another consideration is the potential for other side effects, though these are often mild and transient. These can include fatigue, nausea, constipation, or dizziness. While often manageable, these side effects can impact daily activities and should be discussed with your doctor. Individual responses to medications vary widely, influencing the experience of side effects.

Finally, the cost of AJOVY can be a significant factor. The expense of the medication, and whether or not it is covered by your insurance, should be discussed with your healthcare provider and insurance company. Financial considerations are an important aspect of the overall decision-making process regarding treatment options. Exploring potential cost-saving strategies should be a priority.

  • Ajovy™ Solution For Subcutaneous Injection 150Mg/Ml (1.5Ml), Syringe 1Pc Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Ajovy™ Solution For Subcutaneous Injection 150Mg/Ml (1.5Ml), Syringe 1Pc Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Ajovy™ Solution For Subcutaneous Injection 150Mg/Ml (1.5Ml), Syringe 1Pc Buy Online 6
    [Medical reviewer]

    Dr. David J. Bronster, MD, is a distinguished Professor of Neurology and Neurological Consultant to the Recanati/Miller Transplantation Institute. With an impressive 36-year career in consultative wor...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “AJOVY™ solution for subcutaneous injection 150mg/ml (1.5ml), syringe 1pc”

Your email address will not be published. Required fields are marked

Similar products

EXENZA™ nasal spray 2.5mg/dose, 20 doses 1pc

$79.0
Add to cart

SUMATRIPTAN tablets 50mg, 6pcs

$35.0
Add to cart

SUMATRIPTAN-TEVA™ tablets 100mg, 12pcs

$75.0
Add to cart

SUMATRIPTAN-TEVA™ tablets 50mg, 2pcs

$24.0
Add to cart

SUMAMIGREN™ tablets 100mg, 2pcs

$47.0
Add to cart

SUMAMIGREN™ tablets 100mg, 6pcs

$77.5
Add to cart

SUMAMIGREN™ tablets 50mg, 2pcs

$29.5
Add to cart

SUMAMIGREN™ tablets 50mg, 6pcs

$55.0
Add to cart

SUMATRIPTAN CANON™ tablets 100mg, 10pcs

$57.5
Add to cart

SUMATRIPTAN tablets 100mg, 2pcs

$25.5
Add to cart

SUMATRIPTAN tablets 50mg, 2pcs

$21.5
Add to cart

SUMATRIPTAN-OBL™ tablets 100mg, 2pcs

$24.0
Add to cart

SUMATRIPTAN-OBL™ tablets 50mg, 2pcs

$20.0
Add to cart

SUMATRIPTAN tablets 100mg, 2pcs

$21.5
Add to cart

SPIGELON™ sublingual tablets, 50pcs

$56.0
Add to cart

RELPAX™ tablets 40mg, 6pcs

$137.0
Add to cart

MIGRENIUM™ tablets 65mg+500mg, 20pcs

$24.0
Add to cart

MIGREPAM™ tablets 2.5mg, 2pcs

$37.5
Add to cart

COFETAMINE™ tablets 91.5mg+1mg, 10pcs

$25.5
Add to cart

KAPORIZA™ orally disintegrating tablets 10mg, 6pcs

$68.0
Add to cart

IRINEX™ solution for subcutaneous injection 70mg/ml (1ml), syringes 1pc

$1,934.0
Add to cart

AMIGRENIN™ tablets 100mg, 10pcs

$121.0
Add to cart

AMIGRENIN™ tablets 100mg, 2pcs

$24.0
Add to cart

AMIGRENIN™ tablets 100mg, 6pcs

$97.5
Add to cart
Select your currency